For a local representative 1-877-633-2367
Company Information
Medafor, Inc. develops and markets an innovative breakthrough in hemostatic technology and absorbable hemostats called Microporous Polysaccharide Hemospheres (MPH®). Based in Minneapolis, Minnesota, Medafor’s management and employees have significant experience working in the highly regulated global medical device and biotech community.
About Arista®AH
Microporous Polysaccharide Hemospheres (MPH®) rapidly dehydrate blood and accelerate the body’s natural blood clotting process. The MPH Technology is marketed worldwide under the brand name Arista®AH.
News at Medafor | View All
January 24, 2012
Notice to Shareholders
October 13, 2011
Medafor Recognized as One of Minneapolis' Fastest-Growing Private Companies by Minneapolis/St. Paul Business Journal
July 8, 2011
Medafor Gets Approval to Use Arista®AH for Neurological Surgical Procedures in Canada
Upcoming Events | View All
STS 48th Annual Meeting
January 30 – February 1, 2012
Fort Lauderdale, FL
ACOG Annual Clinical Meeting 2012
May 5-9, 2012
San Diego, CA